Abstract
Biomarkers can be used to aid the diagnosis of a disease (particularly early detection of occult tumours), to aid in the staging of disease, to predict outcome of disease, to act as a surrogate for clinical progression and to monitor responses to treatment. It is therefore important when referring to biomarkers to state exactly which of these indications is being sought. There is a real clinical need for biomarkers in all these stages, especially where patient stratification prior to treatment can considerably improve the outcome of clinical trials. Cancer, being a heterogeneous disease, is unlikely to respond to any one specific treatment and biomarkers that could tell us if the patient and their cancer was resistant to certain drugs would be very useful and, indeed, these are being sought. In an analogous way these are even more necessary with regards to vaccines, which would benefit greatly from patient stratification and early prediction of disease response [1].
Keywords: Biomarkers, cancer vaccines, cytokine profiles
Current Cancer Therapy Reviews
Title: Practical Aspects in the Use of Biomarkers for the Development of Cancer Vaccines
Volume: 4 Issue: 2
Author(s): Angus G. Dalgleish
Affiliation:
Keywords: Biomarkers, cancer vaccines, cytokine profiles
Abstract: Biomarkers can be used to aid the diagnosis of a disease (particularly early detection of occult tumours), to aid in the staging of disease, to predict outcome of disease, to act as a surrogate for clinical progression and to monitor responses to treatment. It is therefore important when referring to biomarkers to state exactly which of these indications is being sought. There is a real clinical need for biomarkers in all these stages, especially where patient stratification prior to treatment can considerably improve the outcome of clinical trials. Cancer, being a heterogeneous disease, is unlikely to respond to any one specific treatment and biomarkers that could tell us if the patient and their cancer was resistant to certain drugs would be very useful and, indeed, these are being sought. In an analogous way these are even more necessary with regards to vaccines, which would benefit greatly from patient stratification and early prediction of disease response [1].
Export Options
About this article
Cite this article as:
Dalgleish G. Angus, Practical Aspects in the Use of Biomarkers for the Development of Cancer Vaccines, Current Cancer Therapy Reviews 2008; 4 (2) . https://dx.doi.org/10.2174/157339408784310098
DOI https://dx.doi.org/10.2174/157339408784310098 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
Call for Papers in Thematic Issues
Current progress in Protein Degradation and Cancer Therapy
argeted Protein Degradation is gaining momentum in cancer therapy, it facilitate targeting undruggable proteins, it overcome cancer resistance and avoid undesirable side effects. Thus small molecules degraders have emerged as novel therapeutic strategy. Targeted protein degradation (TPD), the process of eliminating a protein of interest hold a great promise for ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Basic Mechanisms Involved in the Anti-Cancer Effects of Melatonin
Current Medicinal Chemistry Recent Advances in Biotransformation by Cunninghamella Species
Current Drug Metabolism An Overview on COVID-19 and its Effect on Cardiovascular Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets A Compendium of Volatile Organic Compounds (VOCs) Released By Human Cell Lines
Current Medicinal Chemistry Editorial (Hot Topic: Cancer Imaging: Progress and Prospect)
Current Molecular Imaging (Discontinued) Deregulation of PI3K/Akt/mTOR Signaling Pathways by Isoflavones and its Implication in Cancer Treatment
Anti-Cancer Agents in Medicinal Chemistry New Drug Design for Gene Therapy - Taking Advantage of Introns
Letters in Drug Design & Discovery Combinatorial Nanoparticles for Cancer Diagnosis and Therapy
Current Medicinal Chemistry Imaging of Cyclooxygenase-2 (COX-2) Expression: Potential Use in Diagnosis and Drug Evaluation
Current Pharmaceutical Design Understanding Abnormal c-JNK/p38MAPK Signaling in Amyotrophic Lateral Sclerosis: Potential Drug Targets and Influences on Neurological Disorders
CNS & Neurological Disorders - Drug Targets Management of Locally Advanced Cancer Cervix an Indian Perspective
Reviews on Recent Clinical Trials Current Advances in Anti-Influenza Therapy
Current Medicinal Chemistry The Use of Transient Expression Systems for the Rapid Production of Virus-like Particles in Plants
Current Pharmaceutical Design The Promise of Dolutegravir: A Novel Second Generation Integrase Strand Transfer Inhibitor
Current Clinical Pharmacology Multi-Targeted Agents in Cancer Cell Chemosensitization: What We Learnt from Curcumin Thus Far
Recent Patents on Anti-Cancer Drug Discovery Immunity to Bacterial Infections
Current Immunology Reviews (Discontinued) Exploring Mechanisms of MicroRNA Downregulation in Cancer
MicroRNA Editorial
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery The Value of Elastosonography in Evaluation of Thyroid Nodules
Recent Patents on Medical Imaging Human Papilloma Virus Vaccine Associated Uveitis
Current Drug Safety